FORGING THE CHAIN

Recommendations

Info

2007 – 2012 BAYER Support to implementing Chagas disease control and elimination activities US$ 1.5 million 141 2012 – 2017 BAYER Donated suramin for treatment of HAT patients 10 000 vials in endemic countries per year 2012 – 2017 BAYER Support to implementing Chagas disease US$ 1.5 million control and elimination activities 2012 – 2017 BAYER Donated nifurtimox (120 mg) for treatment 5 million of Chagas disease tablets 2013 – 2015 BAYER Support to reinforce access to health care €300 000 for HAT patients in the Democratic Republic of the Congo 2014 – 2019 BAYER Donated nifurtimox (120 mg) and (30 mg) for 300 000 treatment of human African trypanosomiasis (120 mg) and 20 000 (30 mg) 2012 ANESVAD Support to procuring streptomycin for €208 152 countries where Buruli ulcer is endemic 2013 ALM Support to supplying rifampicin and strepto- US$ 150 000 mycin for WHO Global Buruli Ulcer Initiative programme 2013 ALM Support to implementing WHO Buruli ulcer US$ 150 000 clinical trials 2014 ALM Support to implementing WHO Buruli ulcer US$ 150 000 clinical trials 2014 ALM Support to supplying rifampicin and strepto- US$ 75 000 mycin for WHO Global Buruli Ulcer Initiative programme 2011 – 2015 SANOFI Donated eflornithine, melarsoprol and pent- US$ 25 million amidine, with additional financial support to implementing WHO/IDM activities
142 2011 – 2016 GILEAD Donated quantities of liposomal amphotericin B (lyophilized 50 mg formulation) free of 445 000 vials charge to WHO for use in treating human visceral leishmaniasis in targeted treatment populations in eligible endemic countries 2012 – 2016 DFID Support to WHO/NTD for capacity strength- £2.7 million ening and visceral leishmaniasis programme coordination and elimination programmes (East Africa and South Asia) 2013 – 2015 Bill & Melinda Support to implementing innovative US$ 2.9 million Gates approaches for case detection and Foundation management for sustainable elimination of T.b. gambiense HAT 2014 FIND Support to studies evaluating the sensitivity US$ 80 000 and specificity of fluorescent thin-layer chromatography and PCR for diagnosis of Buruli ulcer 2015 – 2016 TFGH Support to implementing randomized US$ 428 518 controlled trials comparing the efficacy of single-dose treatment against yaws (azithromycin 20mg/kg versus 30 mg/kg) 2015 GE Healthcare Donated DE52 Cellulose and Cytopore 2 50 kg of DE52 Bio-Sciences for use in the manufacture of mAECT for Cellulose AB the detection of HAT parasite and 6 kg of Cytopore 2 2016 – 2018 DFID Support to visceral leishmaniasis control £1 224 830 programmes in East Africa Notes: ALM, American Leprosy Missions; DFID, United Kingdom Department for International Development; FIND, Foundation for Innovative New Diagnostics; GE, General Electric – Healthcare Bio-Sciences AB) GOV., Government; HAT, human African trypanosomiasis; TFGH, Task Force for Global Health; WHO/IDM, WHO Innovative and Intensified Disease Management; WHO/NTD WHO Department of Control of Neglected Tropical Diseases. All the financial figures are from the annual WHO financial reports 2001-2015.
Page 2 and 3:
FORGING THE CHAIN
Page 4 and 5:
“ RESULTS BUILD TRUST, AND WITH T
Page 6:
Acknowledgements Forging the chain:
Page 9 and 10:
8 HAT ↓ HUMAN AFRICAN TRYPANOSOMI
Page 11 and 12:
10 PARTNERING IN THE BATTLE AGAINST
Page 13 and 14:
12 THE TERM “TROPICAL”: LEGENDS
Page 15 and 16:
14 FIVE OR SIX UNIQUE DISEASES? Whe
Page 17 and 18:
16
Page 19 and 20:
18 There is no trust more sacred th
Page 21 and 22:
20 ACCESS TO HEALTH SYSTEMS ACCESS
Page 23 and 24:
A 22 ACCESS TO DIAGNOSIS From a pub
Page 25 and 26:
B 24 BURULI ULCER Buruli ulcer occu
Page 27 and 28:
C 26 LONG-TERM CARE IS A LINK IN TH
Page 29 and 30:
C 28 THE CRUEL TOLL ON CHILDREN “
Page 31 and 32:
C 30 ARMED CONFLICTS: DRIVERS OF EP
Page 33 and 34:
32 WAR IS NOT AN
Page 35 and 36:
34 IT IS A
Page 37 and 38:
36 p42 Added to the dilemma of diag
Page 39 and 40:
D 38 DETECTION RATES Eliminating a
Page 41 and 42:
D 40 DRUG DONATIONS VERSUS PREFEREN
Page 43 and 44:
E 42 THE IMPORTANCE OF EARLY DIAGNO
Page 45 and 46:
E 44 ELIMINATION AND ERADICATION Er
Page 47 and 48:
46 The first is the absolute import
Page 49 and 50:
48
Page 51 and 52:
50 It also means that p53 calculati
Page 53 and 54:
F 52 ANOTHER FRANCO-ANGLO SPAT The
Page 55 and 56:
F 54 “EVEN FREE OF CHARGE IS TOO
Page 57 and 58:
H 56 HUMAN AFRICAN TRYPANOSOMIASIS
Page 59 and 60:
I 58 THE PATH OF INSTITUTIONAL CHAN
Page 61 and 62:
I 60 UNDER- AND OVER-INVESTING A ba
Page 63 and 64:
K 62 KEY ACHIEVEMENTS CHAGAS DISEAS
Page 65 and 66:
K 64 VISCERAL AND CUTANEOUS LEISHMA
Page 67 and 68:
66 EVEN FREE OF
Page 69 and 70:
68 IS TOO EXPENSIVE
Page 71 and 72:
70 I= Alpha.F(K,C) n
Page 73 and 74:
M 72 MAGIC AND DAMNED DISEASES: WHY
Page 75 and 76:
M 74 ANATOMY OF MOBILE TEAMS Screen
Page 77 and 78:
O 76 WHO SAYS OLD DISEASES CAN’T
Page 79 and 80:
P 78 p80 POVERTY, DISEASE, POVERTY
Page 81 and 82:
80 THE PEOPLE’S
Page 83 and 84:
82 MOTHER OF
Page 85 and 86:
84 The more closely people interact
Page 87 and 88:
R 86 FROM THEORY TO REALITY It is i
Page 89 and 90:
R 88 REACHING THE PATIENT: THE LONG
Page 91 and 92: S 90 SAFETY AND EFFECTIVENESS TRUMP
Page 93 and 94: S 92 THE NEED TO REVISIT STRATEGIES
Page 95 and 96: S 94 THE SUSTAINABILITY PUZZLE Sust
Page 97 and 98: T 96 BURULI ULCER TRANSMISSION MYST
Page 99 and 100: 98 As long as poverty, injustice an
Page 101 and 102: 100
Page 103 and 104: 102 IMPROVE WOMEN’S HEALTH, IMPRO
Page 105 and 106: V 104 EARLY SWIPES AT VECTOR CONTRO
Page 107 and 108: V 106 PREYING ON VULNERABILITY Whil
Page 109 and 110: W 108 THE PILL AND THE WILL Yaws is
Page 111: Y 110 YAWS Yaws is a chronic bacter
Page 114 and 115: 113
Page 116 and 117: 115 Industry is present. Your donat
Page 118 and 119: 117
Page 120 and 121: 119
Page 122 and 123: 121
Page 124 and 125: 123
Page 126 and 127: 125
Page 128 and 129: 127
Page 130 and 131: 129
Page 132 and 133: 131
Page 134: 133
Page 137 and 138: 136 ESTIMATED NUMBER OF CASES OF CH
Page 139 and 140: 138 DISTRIBUTION OF VISCERAL LEISHM
Page 141: 140 OFFICIAL AGREEMENTS SIGNED BETW
Page 145: Bibliography Dominican female study
show all

FORGING THE CHAIN

Create successful ePaper yourself

Delete template?

Save as template?